ACS medical and scientific director, Otis Brawley, said these mutations are a very “incomplete picture of a person’s true cancer risk. Most doctors don’t understand this stuff, and that’s what genetic counselors are for.” https://t.co/MCQiKUIoUQ
The FDA's approval of 23andMe’s cancer-risk test is the latest example of the agency’s course reversal. But will consumer access empower people—or confuse them? https://t.co/bCPKxK7weh
February is National Cancer Prevention Month! Here are 10 tips for reducing your risk of developing certain cancers: https://t.co/GwCgc1Zc6i #cancerprevention